Thursday, January 27, 2022   fundraising

Ractigen Therapeutics closes an additional $30 million in Series A+ funding to push development of its RNAa platform

[01/27/2022, Nantong] Ractigen Therapeutics today announced the closing of a Series A+ financing round totaling $30 million led...

News and events

Wednesday, July 12, 2017   News

The first book on RNAa published

Springer•Nature published a book edited by Ractigen’s founder, Dr. Long-Cheng LI and entitled “RNA Activation”. This is the first published book on RNAa and was contributed by over 40 worldwide experts working on RNAa. 

Sunday, June 18, 2017   News

Ractigen Therapeutics officially opens its door for business

[Rudong, China] The grand opening ceremony of Ractigen Therapeutics took place on the morning of June 18th, 2017 in front of Ractigen’s building in the Life-Health Industrial Park, Rudong, Jiangsu. Among the attendants were industrial leaders, industrial and academic experts in the...

Sunday, April 30, 2017   News

HS Talk published a lecture presented by Ractigen’s co-founder and CEO, Dr. Long-Cheng Li

Henry Stewart Talks which publishes animated audio visual presentations by world leading experts published a lecture by Dr. Long-Cheng Li. This lecture entitled "Activation of gene expression by double-stranded RNAs" was recorded at the invitation of HS Talks and can be viewed at this URL:...

Friday, September 2, 2016   News

Ractigen Therapeutics officially incorporated

On September 2, 2016, Ractigen Therapeutics was officially incorporated and registered with the Industry and Commerce Bureau of Nantong, Jiangsu Province.